Researchers have identified which patients with obstructive sleep apnea (OSA) and obesity are likely to see the most significant improvements from GLP-1 tirzepatide treatment, according to data presented at ATS 2026
Weight loss is targeted at a rate of 1-3 lbs per week and works even for those who have a history of frequent or repeat dieting, weight loss resistance, difficulty maintaining weight loss, sugar and carb cravings, peri-menopausal or post-menopausal weight gain, and poor blood sugar control
Current evidence on risk factors for knee osteoarthritis in older adults: a systematic review and meta-analysis
In Australia, semaglutide as Wegovy and tirzepatide as Mounjaro are registered for weight management
These aren't your typical scrubs that leave your face feeling like sandpaperthey're much smarter than that
It's modified with an additional 13 amino acids at the N-terminus and a glutamic acid substitution, which significantly reduces its binding to IGF binding proteins